The mechanism of invasion and migration in cervical cancer and construction of prognosis model based on proteomics

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100054087

Enrollment

Unknown

Registered

2021-12-08

Start date

2021-12-01

Completion date

Unknown

Last updated

2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Interventions

group of tumor recurrence:none

group of non-tumor recurrence:none

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. The clinical stage is IB1-IIA2 (FIGO stage of cervical cancer 2009); 3. Histological types are squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma; 4. The surgical approach is laparotomy; 5. Scope of operation: QM-C hysterectomy + pelvic lymph node resection±abdominal aortic lymph node resection.

Exclusion criteria

Exclusion criteria: 1. Preoperative neoadjuvant chemotherapy or radiotherapy; 2. The effective follow-up time is less than 60 months; 3. Combined with other malignant tumors; 4. Combined pregnancy.

Design outcomes

Primary

Measure	Time frame
Tumor recurrence;	—

Countries

China

Contacts

Public ContactHe Fangjie

The First People's Hospital of Foshan

dr_hefangjie@163.com+86 18250154438

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026